$661 Million is the total value of Rhenman & Partners Asset Management AB's 96 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WBA | New | Walgreens Boots Alliance Inc | $11,240,000 | – | 132,000 | +100.0% | 1.70% | – |
| VRX | New | Valeant Pharm Intl Inc | $7,014,000 | – | 69,000 | +100.0% | 1.06% | – |
| BSX | New | Boston Scientific Corp | $5,053,000 | – | 274,000 | +100.0% | 0.76% | – |
| IONS | New | Ionis Pharmaceuticals Inc | $4,149,000 | – | 67,000 | +100.0% | 0.63% | – |
| LIVN | New | Livanova Plc | $3,918,000 | – | 66,000 | +100.0% | 0.59% | – |
| BXLT | New | Baxalta Inc | $3,435,000 | – | 88,000 | +100.0% | 0.52% | – |
| HZNP | New | Horizon Pharma Plc | $3,164,000 | – | 146,000 | +100.0% | 0.48% | – |
| PCRX | New | Pacira Pharmaceuticals Inc | $2,688,000 | – | 35,000 | +100.0% | 0.41% | – |
| EXEL | New | Exelixis Inc | $2,594,000 | – | 460,000 | +100.0% | 0.39% | – |
| SGNT | New | Sagent Pharmaceuticals Inc | $2,387,000 | – | 150,000 | +100.0% | 0.36% | – |
| FGEN | New | FibroGen Inc | $1,524,000 | – | 50,000 | +100.0% | 0.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-01-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.